Evidence map›Paper›PMID 42115993›Full record

ArticleBMC public health2026

Using a crowdsourcing open call to generate hepatitis B and C stigma-reduction materials with medical students in China.

Yanqi Wang, Thomas Fitzpatrick, Gifty Marley, Shiying Huang, Simin Zhang, Yonglin Yang, Yiwen Sun, Joseph Tucker, Dan Wu

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanqi WangState Key Laboratory of Reproductive Medicine and Offspring Health & National Vaccine Innovation Platform & Department of Social Medicine and Implementation Science, School of Public Health, Nanjing Medical University, Nanjing, China.
Thomas FitzpatrickSchool of Medicine, University of Washington, Seattle, WA, USA.
Gifty MarleyUniversity of North Carolina-Project China, Guangzhou, China.
Shiying HuangState Key Laboratory of Reproductive Medicine and Offspring Health & National Vaccine Innovation Platform & Department of Social Medicine and Implementation Science, School of Public Health, Nanjing Medical University, Nanjing, China.
Simin ZhangDepartment of Social Medicine and Implementation Science, School of Public Health, Nanjing Medical University, Nanjing, China.
Yonglin YangDepartment of Infectious Diseases & Institute of Hepatology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu Province, China.
Yiwen SunStudent Affairs Office, School of Public Health, Nanjing Medical University, Nanjing, China.
Joseph TuckerClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Dan WuState Key Laboratory of Reproductive Medicine and Offspring Health & National Vaccine Innovation Platform & Department of Social Medicine and Implementation Science, School of Public Health, Nanjing Medical University, Nanjing, China. danwu@njmu.edu.cn.ORCID 0000-0003-0415-5467

Funding

Nanjing Medical University KY103R202309
6 · The paper itself

Abstract

backgroundStigma among healthcare providers toward people living with hepatitis B and C can negatively impact quality of care and health outcomes. Stigmatizing perceptions, attitudes, and behaviors are common among trainees, but effective interventions and curricula to reduce stigma are lacking. Crowdsourcing asks a group to solve a public health problem and then share optimal solutions back to the community. We organized a crowdsourcing open call at Nanjing Medical University to generate stigma-reduction materials tailored to medical students.

methodsWe conducted a crowdsourcing open call informed by a World Health Organization practical guide. The open call involved four steps: (1) forming a stakeholder steering committee; (2) promoting the open call on campus; (3) screening and judging entries, which included text, posters, comics, or videos, in Chinese or English. Each submission was scored using prespecified criteria across five dimensions from one (poorest quality) to ten (highest quality) by three independent judges; (4) sharing and evaluating finalist ideas. Thematic analysis was applied to all entries.

resultsThe open call was conducted from September 15 to October 15, 2023. Across online and offline channels, the recruitment materials received over 13,000 views. 170 students participated in the open call and 114 entries were collected, including nine videos, 54 posters or comics, and 51 text submissions. The average score across all entries was 7.3 and the four highest-scoring entries were developed into educational materials. Among all 170 participants, 24% had family or friends living with HBV or HCV and 38% had participated in volunteer activities related to hepatitis. Thematic analysis revealed five core themes: (1) legal rights and protections for people living with hepatitis; (2) hepatitis-related awareness enhancement; (3) social support for people living with hepatitis; (4) hepatitis-friendly healthcare system; and (5) stigma reduction through digital health platforms.

conclusionThis crowdsourcing initiative successfully engaged medical students in generating stigma-reduction materials, demonstrating its feasibility as a participatory approach to developing student-centered educational materials. Further research will focus on the effectiveness of these materials in hepatitis-related stigma reduction.

Indexed as

CrowdsourcingHepatitis BHepatitis CSocial StigmaStudents, MedicalChinaFemaleHumansMaleChinaCrowdsourcingMedical studentsStigmaViral hepatitis

Identifiers

PMID42115993
PMCPMC13335275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.